{"slug":"tirzepatide-ppis","verification":{"valid":true,"entries":2,"head":"b609f7bbcca66ce6a38fdc31a0bb2b762d665c13d50ce861cf93b4577f42cbc8"},"energy":{"passes":2,"tokens_in":13906,"tokens_out":3255,"tokens_total":17161,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"b609f7bbcca66ce6a38fdc31a0bb2b762d665c13d50ce861cf93b4577f42cbc8"},"provenance":[{"ts":"2026-06-29T22:41:02.358Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Ppis\nSlug: tirzepatide-ppis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"PPIs (omeprazole, etc.)\",\"condition_key\":\"ppis\",\"primary_peptide\":\"tirzepatide\",\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[\"ppis\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have PPIs (omeprazole, etc.)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\",\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n3. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n4. *","response":"{\n  \"slug\": \"tirzepatide-ppis\",\n  \"title\": \"Tirzepatide and PPIs: Metabolic Load Reduction While Managing Acid Suppression\",\n  \"body\": \"## What's breaking down if you have PPIs (omeprazole, etc.)\\n\\nPPIs like omeprazole suppress stomach acid production. This addresses symptoms of reflux or ulcers but leaves other layers unaddressed. Long-term acid suppression can alter nutrient absorption, including vitamin B12, magnesium, calcium, and iron. Mucosal changes in the gut lining may also occur over months or years.\\n\\nMechanical factors such as excess body weight still add pressure on the stomach and lower esophageal sphincter. If body weight remains high, intra-abdominal pressure continues to push acid upward even when acid output is lowered by the drug.\\n\\nThe net result is symptom control through suppression rather than resolution of the underlying load that contributes to reflux in the first place.\\n\\n## Why Tirzepatide might help you\\n\\n1. You are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n3. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n4. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nWeight loss of even 5–10% body weight lowers intra-abdominal pressure. Each pound lost reduces lumbar compressive force by approximately four pounds. This mechanical change can ease the push against the esophageal sphincter over time.\\n\\nTirzepatide activates GLP-1 and GIP receptors. Clinical data show average weight reductions of 15–20% over 72 weeks in adults with obesity or overweight plus comorbidities. The resulting drop in body mass directly reduces the physical load component that PPIs do not touch.\\n\\nIf your reflux has a sig","tokens_in":13906,"tokens_out":3255,"cost":0,"prev":"genesis","hash":"1da31ffe32fd26a69720f77c7b4678bfcda6cdadd9327b87f9d014e0700f44f0"},{"ts":"2026-07-17T02:43:19.186Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-ppis","response":"31 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1da31ffe32fd26a69720f77c7b4678bfcda6cdadd9327b87f9d014e0700f44f0","hash":"b609f7bbcca66ce6a38fdc31a0bb2b762d665c13d50ce861cf93b4577f42cbc8"}]}